The best fertility supplements for PCOS are those with randomised-trial evidence for improving ovulation, insulin sensitivity, or egg quality — most consistently myo-inositol, N-acetylcysteine (NAC), vitamin D, omega-3 fatty acids, and coenzyme Q10. None of these supplements replaces medical treatment when one is needed, but each can play a supporting role in a fertility plan built around the phenotype and metabolic profile of polycystic ovary syndrome (PCOS).
Trying to conceive with PCOS often means navigating irregular cycles, insulin resistance, and inflammation alongside the emotional weight of unpredictability. Choosing supplements with a real evidence base — rather than whatever is trending — can make a meaningful difference to how your body responds to lifestyle and medical interventions.
- Five supplements have the strongest fertility-relevant evidence in PCOS: myo-inositol, NAC, vitamin D, omega-3, and CoQ10.
- The 2023 international PCOS guideline notes that inositol should not be used as a stand-alone fertility treatment, but it can support metabolic and ovulatory function alongside medical care.1
- A randomised double-blind trial of 130 women showed that adding NAC to letrozole produced more mature follicles and a modest but statistically significant pregnancy rate improvement (p = 0.045) compared with letrozole plus placebo.2
- Vitamin D deficiency affects an estimated 67–85% of women with PCOS, and supplementation has been associated with higher ovulation and pregnancy rates in meta-analysis.3,4
- Most supplements need around three months of consistent use before fertility effects emerge, reflecting the ~85-day cycle of follicular development.
- PCOS phenotype matters: insulin-resistant phenotypes respond best to inositol, NAC and chromium; lean or adrenal phenotypes may benefit more from CoQ10, omega-3, and vitamin D.
What does the evidence say about supplements for PCOS fertility?
Supplements can meaningfully support PCOS fertility by improving insulin sensitivity, reducing oxidative stress, and supporting follicular development — but they rarely act as stand-alone fertility treatments. Across randomised trials and meta-analyses, the strongest signals come from supplements that target the underlying metabolic and inflammatory features of PCOS rather than the symptoms.1
The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS, developed by Monash University with ESHRE and ASRM,11 made several practice-defining points. It recommended letrozole as the first-line ovulation induction agent and explicitly stated that inositol "should not be recommended" as a stand-alone fertility treatment.1 That does not mean inositol is unhelpful — only that the evidence supports it as adjunctive support, not as a replacement for medical induction.
Below, the supplements are organised by the strength of their fertility evidence in PCOS specifically, not in general infertility populations — so you can see at a glance where the evidence is strongest and where it is more tentative.
Which supplements have the strongest fertility evidence in PCOS?
The five supplements with the most consistent evidence are myo-inositol, NAC, vitamin D, omega-3 fatty acids, and CoQ10. Each addresses a different mechanism in the PCOS picture, which is why they are often combined rather than used in isolation.
Myo-inositol (with or without D-chiro-inositol)
Myo-inositol improves insulin signalling and follicular maturation in PCOS. A 2017 meta-analysis of randomised trials found significant reductions in fasting insulin and HOMA-IR with myo-inositol supplementation, alongside improvements in serum SHBG when taken for at least 24 weeks.5 (The lead authorship of this meta-analysis has industry ties to a myo-inositol manufacturer, and the German cohort cited below was led by an investigator at a myo-inositol distributor; the Cochrane review cited further down offers an independent perspective.) A large German observational cohort of 3,602 infertile women with PCOS reported that 70% restored ovulation during 2–3 months of treatment with myo-inositol 4 g daily plus folic acid, with a 15.1% pregnancy rate over the observation period.6 As an uncontrolled study, it cannot isolate inositol's specific contribution from time and lifestyle effects.
A typical clinical dose is 2 g of myo-inositol twice daily, often combined with D-chiro-inositol in a 40:1 ratio to mimic the physiological inositol balance found in healthy ovaries. Cochrane reviewers concluded that the evidence for inositol's effect on clinical pregnancy and live birth was uncertain, rating the underlying trials as very low quality, though they noted possible improvements in ovulation.7
N-acetylcysteine (NAC)
NAC is an antioxidant and glutathione precursor that has been studied as an ovulation-induction adjuvant. A 2015 systematic review and meta-analysis of 8 randomised trials found that NAC produced higher pregnancy rates than placebo across the placebo-comparison subgroup (pregnancy odds ratio 3.97, 95% CI 2.07–7.59), though in the same analysis NAC was less effective than metformin for pregnancy outcomes (OR 0.40, 95% CI 0.23–0.71).8
A more recent placebo-controlled double-blind trial of 130 women with PCOS at a single Iranian centre reported that adding NAC 1.2 g daily to letrozole produced more mature follicles (a greater number of follicles >18 mm) and a higher pregnancy rate than letrozole plus placebo, though the effect was modest (p = 0.045) and awaits independent replication.2 Typical doses in fertility-focused trials range from 1.2 g to 1.8 g daily — a range your prescriber or fertility specialist can help you settle on if you decide to add it.
Vitamin D
Vitamin D deficiency is highly prevalent in PCOS — an estimated 67–85% of women with the condition have serum 25(OH)D below 20 ng/mL, and low levels correlate with menstrual irregularity, hyperandrogenism, and insulin resistance.3 A 2023 systematic review and meta-analysis of vitamin D supplementation in PCOS found pooled improvements in ovulation rate (RR 1.42, 95% CI 1.14–1.78) and pregnancy rate (RR 1.44, 95% CI 1.28–1.62) compared with controls.4
For most women a maintenance dose of 1,000–2,000 IU daily of vitamin D3 is reasonable, but if you're trying to conceive with PCOS, it's worth having your 25(OH)D level measured so dosing can be matched to your starting point. Reaching the sufficient range (≥20 ng/mL or 50 nmol/L) is the threshold used in the PCOS-fertility meta-analysis above,4 though some endocrine guidelines target ≥30 ng/mL (75 nmol/L) for general health.
Omega-3 fatty acids
Omega-3 fatty acids — primarily EPA and DHA from fish or algae oil — reduce inflammation and improve insulin sensitivity, both relevant to PCOS. A meta-analysis of nine randomised trials in 591 women with PCOS found significant reductions in HOMA-IR, total cholesterol, and triglycerides, with no clear effect on luteinising hormone, total testosterone, or sex hormone binding globulin.9
Trial doses have ranged from roughly 1 g to 4 g of combined EPA + DHA per day. A practical fertility-focused dose is 1–2 g of EPA + DHA daily, in line with the trial protocols pooled in the meta-analysis above. You can also read about how omega-3 supports egg quality more generally in our guide to improving egg quality naturally.
Coenzyme Q10 (CoQ10)
CoQ10 supports mitochondrial energy production in developing eggs and may be particularly useful in clomiphene-resistant PCOS. A randomised controlled trial of 149 women with clomiphene-resistant PCOS at a single Karachi centre, published in the Journal of Reproduction & Infertility, found that adding CoQ10 to clomiphene citrate raised ovulation rates from 19% to 70%, with women receiving the combination roughly six times more likely to conceive than those on clomiphene alone (adjusted OR 6.34, 95% CI 1.45–27.71).10 The effect size is striking but comes from a single modest-sized trial, and replication in larger multi-centre studies would strengthen the recommendation.
Typical fertility-focused CoQ10 doses range from 200 mg to 600 mg daily. If you're over 35, the ubiquinol form may be better absorbed than standard ubiquinone.
How does PCOS phenotype influence which supplements may help?
Not all PCOS looks the same biologically, and supplement choice ideally reflects the dominant biology. The 2003 ESHRE/ASRM-sponsored Rotterdam consensus established the diagnostic framework for PCOS based on combinations of oligo-ovulation, hyperandrogenism, and polycystic ovarian morphology; the four phenotypes (A, B, C, D) using these criteria were formally delineated by the 2012 NIH Evidence-Based Methodology Workshop on PCOS. Beyond that diagnostic system, integrative clinicians often subgroup women with PCOS by dominant biology — insulin-resistant, lean or adrenal-driven, or inflammatory — and supplement choice tends to map more usefully to these biological subgroups than to the Rotterdam phenotype labels. If you're not sure where you sit, it's worth asking your GP or fertility specialist; in practice, many women have features of more than one subgroup.
For the insulin-resistant subgroup (the majority of women with PCOS, often with weight challenges and elevated fasting insulin), inositol, NAC, chromium picolinate, and omega-3 are the most evidence-aligned options. For the lean or adrenal-driven subgroup (normal-weight, less marked insulin resistance, higher DHEA-S), CoQ10, omega-3, vitamin D, and stress-supportive nutrients tend to be more relevant. For the inflammatory subgroup, omega-3 and vitamin D take centre stage.
| Supplement | Primary mechanism | Evidence base | Best biology fit | Typical fertility dose |
|---|---|---|---|---|
| Myo-inositol | Insulin signalling, oocyte quality | A — multiple RCTs and meta-analyses | Insulin-resistant | 2 g twice daily |
| NAC | Antioxidant, ovulation induction adjunct | A — meta-analysis of RCTs | Insulin-resistant, ovulatory | 1.2–1.8 g daily |
| Vitamin D3 | Hormone regulation, follicular function | A — meta-analysis of RCTs | All phenotypes if deficient | 1,000–2,000 IU daily |
| Omega-3 (EPA+DHA) | Anti-inflammatory, insulin sensitivity | B — RCTs + meta-analyses | Inflammatory, insulin-resistant | 1–2 g EPA+DHA daily |
| CoQ10 | Mitochondrial support, egg quality | B — RCT in clomiphene-resistant PCOS | Lean, age 35+ | 200–600 mg daily |
| Chromium picolinate | Insulin sensitivity | B — RCTs of metabolic effects | Insulin-resistant | 200–1,000 µg daily |
Evidence base reflects FertilitySmart's editorial summary of the trial literature cited in this article: A indicates multiple RCTs supported by meta-analysis; B indicates RCTs without confirmatory meta-analysis. The 2023 international PCOS guideline does not assign letter-grade tiers to supplements, so this column is our editorial synthesis rather than a guideline grade.
A more general overview of supplement options is available in our complete guide to fertility supplements.
How long do these supplements take to work?
Most fertility-relevant supplements need around three months of consistent use before measurable benefits appear. This timeline reflects biology rather than marketing — the antral follicle that ovulates in a given cycle began its final ~85-day growth phase roughly three months earlier, so any supplement aiming to influence egg quality, follicular development, or hormonal balance needs that runway.12 (The broader folliculogenesis pathway from primordial follicle takes considerably longer, but the antral phase is where supplemental support is most relevant.)
Insulin-related markers (fasting insulin, HOMA-IR, SHBG) often shift sooner — within 8–12 weeks of inositol or NAC supplementation in clinical trials.5,8 Vitamin D status can normalise within 8–12 weeks of adequate dosing, depending on baseline level. Cycle regularity, when it improves, typically does so by month three or four. If nothing has changed by six months of consistent use alongside lifestyle support, it is reasonable to revisit the plan with your GP or specialist. Our article on how long fertility supplements take to work covers this timeline in more detail.
Are PCOS supplements safe to combine with medication?
The supplements above are generally well tolerated, but they are not free of interactions — particularly relevant for anyone on medication for PCOS, thyroid conditions, or anticoagulation. Always discuss new supplements with a pharmacist or prescriber if you take other medications.
Notable interactions worth flagging: NAC may potentiate the blood-pressure-lowering effect of nitroglycerin and should be used cautiously alongside it. Chromium can interfere with the absorption of levothyroxine and should be taken at least four hours apart, and it can lower blood glucose — worth monitoring if you take insulin or sulfonylureas. Omega-3 at higher doses (above 3 g daily of EPA+DHA) can extend bleeding time and may need to be paused before surgery or adjusted on anticoagulant therapy. CoQ10 can theoretically reduce the effect of warfarin. Vitamin D in doses above 4,000 IU daily for prolonged periods requires monitoring, and supplementation should be discussed with your provider if you have hyperparathyroidism, sarcoidosis, or other conditions affecting calcium metabolism. None of these interactions is a reason to avoid the supplements outright, but they are reasons to involve a clinician.
Once pregnancy is confirmed, discuss with your provider which supplements to continue, adjust, or stop — typical adjustments include reducing higher-dose NAC and CoQ10, pausing chromium, and shifting to a prenatal that meets pregnancy-specific micronutrient needs.
For broader nutritional context that complements supplementation, our fertility diet guide covers the food choices that pair well with these supplements.
How should supplements fit alongside medical PCOS treatment?
Supplements work best as adjuncts to medical care, not as alternatives. The 2023 international PCOS guideline confirms letrozole as first-line for ovulation induction, with metformin recommended for adults with PCOS and BMI ≥ 25 kg/m² for metabolic and anthropometric outcomes; clomiphene, gonadotrophins, and laparoscopic ovarian drilling are second-line options.1 Most fertility specialists are comfortable with patients adding the supplements above to a guideline-aligned medical plan.
A practical sequencing pattern looks like this: weight-neutral lifestyle changes and inositol or NAC during the assessment phase; if ovulation does not return, letrozole-led induction with NAC as an adjuvant for women who have not responded to letrozole alone2; CoQ10 if egg quality is a concern, particularly above age 35; vitamin D and omega-3 throughout, given the underlying deficiencies and inflammation typical of PCOS. The pillar guide on PCOS and fertility covers this clinical pathway in depth, and our myo-inositol guide walks through dosing and stacking specifics.
Frequently Asked Questions
Which supplement should I start with for PCOS fertility?
For most women with PCOS — particularly those with insulin resistance — myo-inositol is the most evidence-aligned starting point. Adding vitamin D (if deficient) and an omega-3 with EPA and DHA covers the metabolic and inflammatory bases. NAC and CoQ10 are useful additions if cycles remain irregular or if egg quality is a concern.
Can I take all of these supplements together?
Stacking myo-inositol, vitamin D, omega-3, and CoQ10 is common in clinical practice and is generally well tolerated. Adding NAC is also reasonable. Stacking more than four or five supplements at once becomes harder to manage and harder to attribute outcomes to, so most fertility practitioners pick three to four core options based on phenotype.
Do I need to take metformin if I am taking inositol?
Not necessarily. Inositol and metformin both improve insulin sensitivity, and head-to-head trials have shown broadly similar effects on ovulation. The 2023 international guideline supports metformin for adults with PCOS and BMI ≥ 25 kg/m² for metabolic outcomes, but inositol is a reasonable alternative or adjunct for women who do not tolerate metformin or prefer a non-pharmaceutical option. This is best decided with your GP or endocrinologist.
How does ovulation respond to NAC in PCOS?
In randomised trials, NAC has improved ovulation rates significantly more than placebo and has been a useful adjuvant when added to clomiphene or letrozole, particularly in women who have not responded to ovulation-induction medication alone.2,8 It is less effective than metformin head-to-head, but the side-effect profile is more favourable for many women.
What about herbal supplements like chasteberry (Vitex)?
Chasteberry is sometimes used to support cycle regularity and may help women with luteal phase concerns. The evidence in PCOS specifically is limited, and chasteberry can interact with dopaminergic medications and hormonal therapies. Our chasteberry guide covers the evidence in detail.
Should men with partners who have PCOS take fertility supplements too?
Sperm quality contributes to roughly half of conception outcomes regardless of female fertility factors, so a partner-inclusive approach is sensible. CoQ10, zinc, selenium, and omega-3 all have evidence in male fertility support. Our fertility supplements for couples guide covers this.
Can supplements alone restore ovulation in PCOS?
For some women — particularly those with milder PCOS and modest insulin resistance — combined lifestyle changes and inositol can restore ovulatory cycles within three to six months. For most women with more pronounced PCOS, supplements support but do not replace medical ovulation induction with letrozole or clomiphene.
Supporting Your Fertility with FertilitySmart
PCOS-related fertility challenges often reflect a combination of insulin resistance, oxidative stress, and micronutrient gaps that respond best to a layered approach — diet, lifestyle, medical care where needed, and targeted supplementation. Several of the nutrients discussed in this guide form part of comprehensive preconception support.
At FertilitySmart, we offer both fertility supplements for women and fertility supplements for men that contain key nutrients for fertility, including CoQ10, folate, zinc, and selenium. Explore our range of evidence-based fertility supplements designed to complement a PCOS-aware diet and supplement plan.
Related Reading
- PCOS and Fertility: How to Improve Your Chances Naturally
The pillar guide for PCOS-related fertility, covering diagnosis, treatment pathways, and lifestyle support. - Myo-Inositol for Fertility and PCOS
Deep dive into the most-studied PCOS supplement, including the 40:1 ratio rationale and clinical evidence. - Chasteberry (Vitex) for Fertility
Evidence and cautions for the most common herbal supplement used in PCOS. - How to Improve Egg Quality Naturally
Why CoQ10 and antioxidants matter for follicular development. - What Does CoQ10 Do for Fertility?
Mechanism and clinical evidence for CoQ10 in egg quality and PCOS. - Magnesium and Fertility
A supporting nutrient often deficient in PCOS. - How Long Do Fertility Supplements Take to Work?
The 90-day rule and what to expect. - A Complete Guide to Fertility Supplements
Broader overview of supplement options for both partners. - Fertility Diet
Food choices that complement supplementation in PCOS. - How to Increase Ovulation Naturally
Lifestyle and nutrition strategies for ovulatory regularity.
References
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi.org/10.1210/clinem/dgad463
- Mostajeran F, Tehrani HG, Rahbary B. N-Acetylcysteine as an adjuvant to letrozole for induction of ovulation in infertile patients with polycystic ovary syndrome. Adv Biomed Res. 2018;7:100. pubmed.ncbi.nlm.nih.gov/30050888
- Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77(3):343-350. doi.org/10.1111/j.1365-2265.2012.04434.x
- Yang M, Shen X, Lu D, et al. Effects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1148556. doi.org/10.3389/fendo.2023.1148556
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658. doi.org/10.1530/EC-17-0243
- Regidor PA, Schindler AE. Myoinositol as a safe and alternative approach in the treatment of infertile PCOS women: a German observational study. Int J Endocrinol. 2016;2016:9537632. doi.org/10.1155/2016/9537632
- Showell MG, Mackenzie-Proctor R, Jordan V, Hodgson R, Farquhar C. Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;12(12):CD012378. doi.org/10.1002/14651858.CD012378.pub2
- Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015;2015:817849. doi.org/10.1155/2015/817849
- Yang K, Zeng L, Bao T, Ge J. Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018;16(1):27. doi.org/10.1186/s12958-018-0346-x
- Izhar R, Husain S, Tahir MA, Husain S. Effect of administrating coenzyme Q10 with clomiphene citrate on ovulation induction in polycystic ovary syndrome cases with resistance to clomiphene citrate: a randomized controlled trial. J Reprod Infertil. 2022;23(3):177-183. pubmed.ncbi.nlm.nih.gov/36415489
- Monash Centre for Health Research and Implementation. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023. Melbourne: Monash University; 2023. monash.edu/medicine/mchri/pcos
- Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986;1(2):81-87. doi.org/10.1093/oxfordjournals.humrep.a136365
Marina Carter
Health & Fertility Writer at FertilitySmart
Marina Carter is the Health & Fertility Writer at FertilitySmart, specialising in evidence-based content on reproductive health, preconception nutrition, and fertility supplementation. She has spent the past decade translating peer-reviewed research into practical guidance for individuals and couples trying to conceive, with a particular focus on conditions such as PCOS, endometriosis, and unexplained infertility. Read Full Bio →